The central nervous system effects of the partial GABA-Aα2,3 -selective receptor modulator AZD7325 in comparison with lorazepam in healthy males.
about
GABAA receptor occupancy by subtype selective GABAAα2,3 modulators: PET studies in humans.Pharmacology in translation; the preclinical and early clinical profile of the novel α2/3 functionally selective GABAA receptor positive allosteric modulator PF-06372865.Synthesis of C-14 Labeled GABAA α2/α3 Selective Partial Agonists and the Investigation of Late-Occurring and Long-Circulating Metabolites of GABAA Receptor Modulator AZD7325.Pharmacodynamic response profiles of anxiolytic and sedative drugs.Mirogabalin and emerging therapies for diabetic neuropathy
P2860
The central nervous system effects of the partial GABA-Aα2,3 -selective receptor modulator AZD7325 in comparison with lorazepam in healthy males.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The central nervous system eff ...... th lorazepam in healthy males.
@en
The central nervous system eff ...... th lorazepam in healthy males.
@nl
type
label
The central nervous system eff ...... th lorazepam in healthy males.
@en
The central nervous system eff ...... th lorazepam in healthy males.
@nl
prefLabel
The central nervous system eff ...... th lorazepam in healthy males.
@en
The central nervous system eff ...... th lorazepam in healthy males.
@nl
P2093
P2860
P356
P1476
The central nervous system eff ...... ith lorazepam in healthy males
@en
P2093
Adam Cohen
Gabriël Jacobs
Jaakko Lappalainen
Joop van Gerven
Judith Jaeger
Marieke de Kam
Mark A Smith
P2860
P304
P356
10.1111/BCP.12413
P407
P577
2014-12-01T00:00:00Z